PGIM India’s Rs 112 crore Healthcare Fund is looking beyond conventional pharmaceutical stocks, with its portfolio focused on contract development and manufacturing organisations, specialty pharma and select healthcare services companies.
The fund, which delivered a 22% return over the past year, has generated alpha through a combination of concentrated stock-picking and exposure to faster-growing healthcare segments, according to Anandha Padmanabhan, senior fund manager, equities, PGIM India Mutual Fund.
